The Oncology Institute (TOI)
(Real Time Quote from BATS)
$0.58 USD
-0.02 (-2.69%)
Updated May 22, 2024 12:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TOI 0.58 -0.02(-2.69%)
Will TOI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TOI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TOI
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
TOI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
Elevance Health (ELV) Q3 Earnings Top Estimates
Other News for TOI
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
The Oncology Institute, Inc. (TOI) Q1 2024 Earnings Call Transcript
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...